Galapagos NV (GLPG)
USD 23.52
(2.08%)
USD 23.52
(2.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.35 Billion EUR | -7.96% |
| 2022 | 4.73 Billion EUR | -8.83% |
| 2021 | 5.19 Billion EUR | -9.17% |
| 2020 | 5.71 Billion EUR | -5.78% |
| 2019 | 6.06 Billion EUR | 321.58% |
| 2018 | 1.43 Billion EUR | 11.91% |
| 2017 | 1.28 Billion EUR | 18.73% |
| 2016 | 1.08 Billion EUR | 144.81% |
| 2015 | 442.51 Million EUR | 63.61% |
| 2014 | 270.46 Million EUR | -5.88% |
| 2013 | 287.37 Million EUR | 22.12% |
| 2012 | 235.32 Million EUR | 46.12% |
| 2011 | 161.05 Million EUR | -16.97% |
| 2010 | 193.96 Million EUR | 34.97% |
| 2009 | 143.7 Million EUR | 20.94% |
| 2008 | 118.82 Million EUR | -20.1% |
| 2007 | 148.72 Million EUR | -11.29% |
| 2006 | 167.64 Million EUR | 105.54% |
| 2005 | 81.56 Million EUR | 422.4% |
| 2004 | 15.61 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.36 Billion EUR | 0.09% |
| 2024 Q2 | 4.29 Billion EUR | -1.63% |
| 2023 Q4 | 4.35 Billion EUR | -2.11% |
| 2023 Q1 | 4.63 Billion USD | -2.16% |
| 2023 Q3 | 4.45 Billion EUR | -1.57% |
| 2023 Q2 | 4.52 Billion EUR | -2.37% |
| 2023 FY | 4.35 Billion EUR | -7.96% |
| 2022 Q3 | 4.97 Billion EUR | -1.35% |
| 2022 Q4 | 4.73 Billion EUR | -4.78% |
| 2022 FY | 4.73 Billion EUR | -8.83% |
| 2022 Q1 | 5.1 Billion EUR | -1.79% |
| 2022 Q2 | 5.04 Billion EUR | -1.18% |
| 2021 Q4 | 5.19 Billion EUR | -2.6% |
| 2021 FY | 5.19 Billion EUR | -9.17% |
| 2021 Q2 | 5.43 Billion EUR | -3.28% |
| 2021 Q3 | 5.33 Billion EUR | -1.82% |
| 2021 Q1 | 5.61 Billion EUR | -1.8% |
| 2020 Q3 | 5.72 Billion EUR | -2.23% |
| 2020 Q1 | 5.99 Billion EUR | -1.26% |
| 2020 FY | 5.71 Billion EUR | -5.78% |
| 2020 Q4 | 5.71 Billion EUR | -0.06% |
| 2020 Q2 | 5.85 Billion EUR | -2.35% |
| 2019 Q1 | 1.4 Billion EUR | -2.73% |
| 2019 Q4 | 6.06 Billion EUR | 3.71% |
| 2019 FY | 6.06 Billion EUR | 321.58% |
| 2019 Q2 | 1.35 Billion EUR | -3.02% |
| 2019 Q3 | 5.85 Billion EUR | 330.96% |
| 2018 Q1 | 1.22 Billion EUR | -4.39% |
| 2018 FY | 1.43 Billion EUR | 11.91% |
| 2018 Q4 | 1.43 Billion EUR | -3.1% |
| 2018 Q3 | 1.48 Billion EUR | 23.35% |
| 2018 Q2 | 1.2 Billion EUR | -2.07% |
| 2017 Q2 | 1.36 Billion EUR | 27.55% |
| 2017 FY | 1.28 Billion EUR | 18.73% |
| 2017 Q1 | 1.07 Billion EUR | -0.97% |
| 2017 Q3 | 1.33 Billion EUR | -2.7% |
| 2017 Q4 | 1.28 Billion EUR | -3.39% |
| 2016 Q2 | 1.06 Billion EUR | -1.18% |
| 2016 Q4 | 1.08 Billion EUR | 3.86% |
| 2016 FY | 1.08 Billion EUR | 144.81% |
| 2016 Q3 | 1.04 Billion EUR | -2.2% |
| 2016 Q1 | 1.07 Billion EUR | 143.9% |
| 2015 Q1 | - EUR | -100.0% |
| 2015 Q4 | 442.51 Million EUR | -4.02% |
| 2015 Q3 | 461.04 Million EUR | -5.57% |
| 2015 Q2 | 488.26 Million EUR | 0.0% |
| 2015 FY | 442.51 Million EUR | 63.61% |
| 2014 Q4 | 270.46 Million EUR | 0.0% |
| 2014 FY | 270.46 Million EUR | -5.88% |
| 2014 Q2 | 304.98 Million EUR | 0.0% |
| 2014 Q1 | 304.98 Million EUR | 6.13% |
| 2013 Q1 | 276.22 Million EUR | 17.38% |
| 2013 Q4 | 287.37 Million EUR | 0.0% |
| 2013 FY | 287.37 Million EUR | 22.12% |
| 2013 Q2 | 276.22 Million EUR | 0.0% |
| 2013 Q3 | 287.37 Million EUR | 4.04% |
| 2012 Q3 | 235.32 Million EUR | -3.29% |
| 2012 Q4 | 235.32 Million EUR | 0.0% |
| 2012 Q2 | 243.33 Million EUR | 0.0% |
| 2012 FY | 235.32 Million EUR | 46.12% |
| 2011 Q2 | 152.98 Million EUR | 0.0% |
| 2011 Q4 | 161.05 Million EUR | 0.0% |
| 2011 FY | 161.05 Million EUR | -16.97% |
| 2010 Q2 | 139.73 Million EUR | 0.0% |
| 2010 FY | 193.96 Million EUR | 34.97% |
| 2010 Q4 | 193.96 Million EUR | 0.0% |
| 2009 FY | 143.7 Million EUR | 20.94% |
| 2009 Q2 | 106.21 Million EUR | 0.0% |
| 2009 Q4 | 143.7 Million EUR | 0.0% |
| 2008 Q4 | 118.82 Million EUR | 0.0% |
| 2008 FY | 118.82 Million EUR | -20.1% |
| 2007 FY | 148.72 Million EUR | -11.29% |
| 2006 FY | 167.64 Million EUR | 105.54% |
| 2005 FY | 81.56 Million EUR | 422.4% |
| 2004 FY | 15.61 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 241.7 Million USD | -1702.789% |
| Jaguar Health, Inc. | 50.76 Million USD | -8483.803% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1077.595% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -8494.978% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -13.774% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -423.057% |
| ContextLogic Inc. | 423 Million USD | -930.117% |
| MiMedx Group, Inc. | 239.04 Million USD | -1722.82% |
| MEI Pharma, Inc. | 41.37 Million USD | -10431.471% |
| AlloVir, Inc. | 190.79 Million USD | -2183.798% |
| Novavax, Inc. | 1.85 Billion USD | -134.857% |
| Aptorum Group Limited | 20.64 Million USD | -21011.322% |
| Ardelyx, Inc. | 297.57 Million USD | -1364.282% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -469.184% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -384774.916% |
| Vaxcyte, Inc. | 1.4 Billion USD | -209.492% |
| Precigen, Inc. | 151.04 Million USD | -2784.871% |
| Pharming Group N.V. | 462.85 Million USD | -841.419% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -952.913% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -11165.243% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -3617.122% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -593.24% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -84187.196% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -22926.162% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -22926.162% |
| Bicycle Therapeutics plc | 595.34 Million USD | -631.912% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -2535.734% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -9521.737% |
| Acelyrin, Inc. | 742.69 Million USD | -486.705% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -67952.413% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -5758.762% |
| Senti Biosciences, Inc. | 119.48 Million USD | -3546.845% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -1808.276% |
| AbCellera Biologics Inc. | 1.48 Billion USD | -192.817% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -52633.825% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -5812.181% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -828.702% |
| Chimerix, Inc. | 212.77 Million USD | -1947.899% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -3423.89% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -13346.263% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -15312.194% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -7586.086% |
| Elevation Oncology, Inc. | 89.09 Million USD | -4790.95% |
| Alkermes plc | 2.13 Billion USD | -103.977% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2501.027% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2501.027% |
| Agenus Inc. | 313.91 Million USD | -1288.09% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -2600.804% |
| Dyadic International, Inc. | 8.21 Million USD | -52914.611% |
| ImmuCell Corporation | 43.8 Million USD | -9846.553% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -13628.406% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -571.075% |
| Lantern Pharma Inc. | 43.64 Million USD | -9883.125% |
| Immix Biopharma, Inc. | 19.92 Million USD | -21768.813% |
| Incyte Corporation | 6.78 Billion USD | 35.752% |
| IO Biotech, Inc. | 150.71 Million USD | -2791.092% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1045.456% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -29937.237% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -13389.972% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -2491.005% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -70157.917% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -1931.363% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -580.262% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -821.537% |
| NextCure, Inc. | 129.41 Million USD | -3266.917% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -7977.03% |
| Onconetix, Inc. | 88.82 Million USD | -4805.793% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -11763.639% |
| Opthea Limited | 188.79 Million USD | -2208.05% |
| PDS Biotechnology Corporation | 59.39 Million USD | -7236.909% |
| PureTech Health plc | 693.97 Million USD | -527.891% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -2408.2% |
| Seer, Inc. | 436.26 Million USD | -898.787% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -66056.241% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -12709.089% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -91177.917% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -4360.66% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -1484.802% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -1178.586% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1057.494% |
| ChromaDex Corporation | 54.96 Million USD | -7827.727% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -43021.188% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -888.143% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -95.437% |
| Precision BioSciences, Inc. | 159.78 Million USD | -2627.105% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -760.776% |
| Innoviva, Inc. | 1.24 Billion USD | -250.412% |
| Summit Therapeutics Inc. | 202.94 Million USD | -2047.04% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -5240.142% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -3190.513% |
| ESSA Pharma Inc. | 149.12 Million USD | -2822.032% |
| GlycoMimetics, Inc. | 45.31 Million USD | -9515.479% |
| GT Biopharma, Inc. | 14.1 Million USD | -30783.805% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -1315.231% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -823.359% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -4476.52% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -689811.145% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -669.394% |
| Aptose Biosciences Inc. | 12.92 Million USD | -33619.336% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -19603.989% |
| Soligenix, Inc. | 9.79 Million USD | -44375.36% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1108.069% |
| Kura Oncology, Inc. | 448.93 Million USD | -870.607% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -1501.107% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -25094.542% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -3828.721% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -2023.995% |
| Autolus Therapeutics plc | 375.38 Million USD | -1060.793% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -1631.627% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1126.8% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -8768.754% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -559.079% |
| GRI Bio, Inc. | 2.95 Million USD | -147308.525% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -40987.253% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -2455.433% |
| IGM Biosciences, Inc. | 423.41 Million USD | -929.117% |
| INmune Bio, Inc. | 57 Million USD | -7544.42% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -1858.327% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5091.007% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -16584.227% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -63204.846% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -5692.407% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -2859.022% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -2532.804% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -592.085% |
| Verastem, Inc. | 149.71 Million USD | -2810.402% |
| Abeona Therapeutics Inc. | 64 Million USD | -6708.218% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -750.798% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -2721.106% |
| Histogen Inc. | 19.07 Million USD | -22745.887% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -19137.804% |
| Surrozen, Inc. | 46.08 Million USD | -9356.155% |
| Organovo Holdings, Inc. | 6.34 Million USD | -68531.218% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -101032.056% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -2925.407% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -36820.827% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -5689.175% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -51047.648% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1100.487% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -23981.466% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -914.759% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -34450.371% |
| Apollomics, Inc. | 55.38 Million USD | -7767.182% |
| Amarin Corporation plc | 831.68 Million USD | -423.924% |
| Mesoblast Limited | 669.15 Million USD | -551.181% |
| Turnstone Biologics Corp. | 112.81 Million USD | -3762.426% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -656.809% |
| Synaptogenix, Inc. | 31.11 Million USD | -13904.765% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -35663.263% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -695.055% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -74103.037% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -59223.372% |
| Exelixis, Inc. | 2.94 Billion USD | -48.092% |
| Better Therapeutics, Inc. | 22.94 Million USD | -18892.268% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1095.317% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -452.457% |
| NLS Pharmaceutics AG | 1.84 Million USD | -235863.352% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -54513.308% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -29552.235% |
| Gritstone bio, Inc. | 177.76 Million USD | -2351.156% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4468.459% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -24294.413% |
| Avid Bioservices, Inc. | 336.55 Million USD | -1194.698% |
| Insmed Incorporated | 1.32 Billion USD | -227.664% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -45155.919% |
| MediWound Ltd. | 66.45 Million USD | -6456.518% |
| OmniAb, Inc. | 401.98 Million USD | -983.97% |
| Alector, Inc. | 621.82 Million USD | -600.741% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1115.113% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -80922.611% |
| Zai Lab Limited | 1.03 Billion USD | -320.478% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -810.724% |
| Aura Biosciences, Inc. | 255.07 Million USD | -1608.28% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -480.964% |
| Immunic, Inc. | 54.29 Million USD | -7924.818% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -1536.74% |
| Veracyte, Inc. | 1.13 Billion USD | -282.96% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -36755.928% |
| FibroGen, Inc. | 423.52 Million USD | -928.831% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -123936.322% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -91894.076% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -80154.419% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 61.755% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -49387.746% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -742.084% |
| TG Therapeutics, Inc. | 329.58 Million USD | -1222.078% |
| Galecto, Inc. | 38.22 Million USD | -11298.739% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -15095.271% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -0.004% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -1751.029% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -17440.44% |
| XBiotech Inc. | 227.24 Million USD | -1817.505% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4468.459% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -2955.677% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -1424.013% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -3307.703% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1040.683% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -192.244% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1094.324% |
| Vaxxinity, Inc. | 44.35 Million USD | -9724.355% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -742.888% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -23315.114% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -1328.42% |
| NexImmune, Inc. | 8.59 Million USD | -50603.07% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -40565.597% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -25341.096% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 86.828% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -19571.212% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1110729.669% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -2413.945% |
| Ainos, Inc. | 31.84 Million USD | -13584.514% |
| Pluri Inc. | 39.52 Million USD | -10923.847% |
| Prothena Corporation plc | 696.38 Million USD | -525.719% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -1441.808% |
| Celularity Inc. | 143.88 Million USD | -2928.304% |
| Rallybio Corporation | 115.62 Million USD | -3668.722% |
| Cue Biopharma, Inc. | 61.53 Million USD | -6981.742% |
| MeiraGTx Holdings plc | 458.16 Million USD | -851.048% |
| Omeros Corporation | 378.26 Million USD | -1051.931% |
| Humacyte, Inc. | 128.22 Million USD | -3298.295% |
| Immunocore Holdings plc | 597 Million USD | -629.881% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -13839.653% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -6258.377% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -315.287% |
| CalciMedica, Inc. | 12.18 Million USD | -35660.328% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -1617.877% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -2449.556% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -1300.934% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -670.813% |
| Pulmatrix, Inc. | 33.95 Million USD | -12731.722% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -15951.706% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -2993.467% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -234.933% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -3246.976% |
| Cytokinetics, Incorporated | 824.31 Million USD | -428.607% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -20528.68% |
| Nutriband Inc. | 7.51 Million USD | -57866.033% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -5418.905% |
| Vor Biopharma Inc. | 209.82 Million USD | -1976.651% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 39.669% |
| Evogene Ltd. | 51.1 Million USD | -8427.027% |
| ProKidney Corp. | 420.55 Million USD | -936.113% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -7846.667% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -45669.63% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -697.503% |
| CorMedix Inc. | 82.05 Million USD | -5210.015% |
| BioLineRx Ltd. | 63.92 Million USD | -6716.419% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -982.403% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -15351.759% |
| Atai Life Sciences N.V. | 293.47 Million USD | -1384.744% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -2571.128% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -3319.765% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -675.3% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -4405.212% |
| MediciNova, Inc. | 66.26 Million USD | -6475.219% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -4854.514% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -97547.682% |
| GeoVax Labs, Inc. | 9.28 Million USD | -46838.417% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -640.756% |
| Biomea Fusion, Inc. | 199.92 Million USD | -2079.494% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -128.953% |
| Mereo BioPharma Group plc | 66.49 Million USD | -6452.574% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -798.254% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -610.97% |
| Absci Corporation | 234.48 Million USD | -1758.323% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -59467.956% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -1181.998% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -2539.534% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -727.895% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -1469.141% |
| Allakos Inc. | 243.61 Million USD | -1688.677% |
| Imunon, Inc. | 21.91 Million USD | -19780.383% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -1590.919% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -601.09% |
| BioAtla, Inc. | 119.65 Million USD | -3541.542% |
| NLS Pharmaceutics AG | 1.84 Million USD | -235863.352% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -135222.857% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -577.838% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -4442.029% |
| XOMA Corporation | 234.3 Million USD | -1759.743% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -1869.578% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -3362.538% |
| aTyr Pharma, Inc. | 122.06 Million USD | -3469.676% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -2731.261% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -650.924% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -788.496% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -3844.451% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -28647.346% |
| Akari Therapeutics, Plc | 4.35 Million USD | -99955.017% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -25475.576% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -151.397% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -141191.043% |
| UroGen Pharma Ltd. | 178.31 Million USD | -2343.706% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -825.656% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -784006.242% |
| Orgenesis Inc. | 14.55 Million USD | -29843.623% |
| Entera Bio Ltd. | 11.76 Million USD | -36936.94% |
| GH Research PLC | 226.3 Million USD | -1825.495% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -7866.863% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -3955.806% |
| Xencor, Inc. | 952.69 Million USD | -357.377% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -55880.527% |
| Replimune Group, Inc. | 487.72 Million USD | -793.418% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -53887.708% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -571.981% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -141191.043% |
| Portage Biotech Inc. | 7.77 Million USD | -55914.861% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -97547.682% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -1473.38% |
| OncoCyte Corporation | 74.89 Million USD | -5718.24% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -214207.158% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -75200.93% |
| Purple Biotech Ltd. | 44.3 Million USD | -9735.664% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -12668.552% |
| scPharmaceuticals Inc. | 94.47 Million USD | -4512.026% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -24047.443% |
| HilleVax, Inc. | 344.43 Million USD | -1165.089% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -137097.607% |
| Tharimmune, Inc. | 10.94 Million USD | -39706.683% |
| Genprex, Inc. | 10.67 Million USD | -40735.56% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -778.162% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -4427.071% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -179512.366% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -104508.276% |
| OKYO Pharma Limited | 1.54 Million USD | -282615.745% |
| Savara Inc. | 177.56 Million USD | -2353.986% |
| Curis, Inc. | 77.28 Million USD | -5538.306% |
| Daré Bioscience, Inc. | 21.28 Million USD | -20374.354% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -6713.882% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -53788.152% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -22394.43% |
| BeiGene, Ltd. | 5.8 Billion USD | 24.941% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -35707.347% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -108.628% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1117.316% |
| Erasca, Inc. | 395.29 Million USD | -1002.309% |
| bluebird bio, Inc. | 619.16 Million USD | -603.758% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -100687.048% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 36.31% |
| DBV Technologies S.A. | 182.98 Million USD | -2281.273% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -100687.048% |
| Moderna, Inc. | 18.42 Billion USD | 76.352% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -23819.394% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -37509.149% |
| Molecular Templates, Inc. | 35.38 Million USD | -12214.942% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -3051.482% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -452.329% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -1334.51% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -4091.98% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -835.813% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -1290.198% |
| MacroGenics, Inc. | 306.82 Million USD | -1320.18% |
| RenovoRx, Inc. | 1.46 Million USD | -297130.286% |
| Adicet Bio, Inc. | 207.29 Million USD | -2002.027% |
| Prime Medicine, Inc. | 193.85 Million USD | -2147.807% |
| Aditxt, Inc. | 44.57 Million USD | -9674.696% |
| Adagene Inc. | 115.72 Million USD | -3665.177% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -97726.922% |
| Quantum-Si incorporated | 298.25 Million USD | -1360.988% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -192.944% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -56422.59% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1140.43% |
| SciSparc Ltd. | 11.18 Million USD | -38867.948% |
| Vericel Corporation | 353.65 Million USD | -1132.097% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -35579.485% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -7557.907% |
| Generation Bio Co. | 374.75 Million USD | -1062.723% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -1611.024% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -2647.984% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -1176.462% |
| Invivyd, Inc. | 229.18 Million USD | -1801.29% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -416.291% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -35706.461% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -2289.054% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -21234.685% |
| 2seventy bio, Inc. | 565.42 Million USD | -670.639% |
| ADMA Biologics, Inc. | 329.18 Million USD | -1223.704% |
| Clene Inc. | 52.34 Million USD | -8225.015% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -7318.823% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -3254.578% |
| GeoVax Labs, Inc. | 9.28 Million USD | -46838.417% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -566.575% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -4105.528% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -3241.92% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -4366.74% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -6037.437% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -1696.472% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -122.306% |
| Evaxion Biotech A/S | 12.88 Million USD | -33708.091% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -1628.714% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -478.911% |
| Trevena, Inc. | 40.6 Million USD | -10631.181% |
| Surrozen, Inc. | 46.08 Million USD | -9356.155% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -1829.272% |
| Cingulate Inc. | 3.49 Million USD | -124702.402% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -26103.596% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -6533.271% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -37191.7% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -1522.764% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -481.796% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -3361.218% |
| Clearmind Medicine Inc. | 4.32 Million USD | -100663.275% |
| Kronos Bio, Inc. | 213.27 Million USD | -1943.05% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -2627.054% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -50800.532% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1082.5% |
| Statera Biopharma, Inc. | 21.16 Million USD | -20483.188% |
| ImmunityBio, Inc. | 504.45 Million USD | -763.788% |
| Korro Bio, Inc. | 221.66 Million USD | -1865.775% |
| Kineta, Inc. | 10.28 Million USD | -42282.998% |
| BioVie Inc. | 25.2 Million USD | -17185.53% |
| Codexis, Inc. | 136.56 Million USD | -3090.806% |
| Celularity Inc. | 143.88 Million USD | -2928.304% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -585.823% |
| Celcuity Inc. | 191.21 Million USD | -2178.742% |
| Virax Biolabs Group Limited | 5.48 Million USD | -79356.977% |
| Cibus, Inc. | 544.41 Million USD | -700.387% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -3361.163% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -21110.066% |
| IN8bio, Inc. | 33.7 Million USD | -12826.506% |
| Kodiak Sciences Inc. | 479.37 Million USD | -808.98% |
| Annexon, Inc. | 297.67 Million USD | -1363.815% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -2418.58% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -3069.73% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -20656.424% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -45.729% |
| Eyenovia, Inc. | 28.77 Million USD | -15040.691% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -1790.181% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -60218.328% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -7051.948% |
| Arcellx, Inc. | 825.13 Million USD | -428.085% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -5237.526% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -842.598% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -14070.393% |
| Moolec Science SA | 24.05 Million USD | -18017.1% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -1305.045% |
| Geron Corporation | 394.07 Million USD | -1005.725% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -4184.137% |
| Royalty Pharma plc | 16.38 Billion USD | 73.401% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -632.375% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -62194.657% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -36129.164% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -1827.54% |
| Humacyte, Inc. | 128.22 Million USD | -3298.295% |
| Structure Therapeutics Inc. | 482.01 Million USD | -803.992% |
| 89bio, Inc. | 596.26 Million USD | -630.777% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -1628.083% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -235434.919% |
| Genelux Corporation | 27.89 Million USD | -15521.826% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -4773.881% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -1799.235% |
| Notable Labs, Ltd. | 19.54 Million USD | -22198.736% |
| Liquidia Corporation | 120.43 Million USD | -3518.168% |
| Mustang Bio, Inc. | 17.74 Million USD | -24459.779% |
| Immunovant, Inc. | 666.71 Million USD | -553.565% |
| Quantum-Si incorporated | 298.25 Million USD | -1360.988% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -2917.566% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -7945.414% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -2382.196% |
| Acasti Pharma Inc. | 73.3 Million USD | -5844.606% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -95618.959% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -16584.227% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -351.638% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -83858.86% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -19027.325% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -8344.075% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -2311.518% |
| PepGen Inc. | 143.05 Million USD | -2946.022% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -11301.722% |
| United Therapeutics Corporation | 7.16 Billion USD | 39.202% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -22612.515% |
| Solid Biosciences Inc. | 164.93 Million USD | -2541.823% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -74103.037% |
| Immuneering Corporation | 102.58 Million USD | -4147.615% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -101032.056% |
| Silo Pharma, Inc. | 7.74 Million USD | -56152.475% |
| Belite Bio, Inc | 94.64 Million USD | -4504.083% |
| XOMA Corporation | 234.3 Million USD | -1759.743% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -1768.619% |
| Bionomics Limited | 27.64 Million USD | -15659.635% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -985.539% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -3957.619% |
| uniQure N.V. | 831.68 Million USD | -423.921% |
| Cassava Sciences, Inc. | 151.66 Million USD | -2773.078% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -97726.922% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -1490.958% |
| Forte Biosciences, Inc. | 38.98 Million USD | -11078.543% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -106879.476% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -11730.784% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -60218.328% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -123936.322% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -36761.484% |
| Altimmune, Inc. | 210.64 Million USD | -1968.646% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -460.163% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -3957.619% |
| Compugen Ltd. | 121.33 Million USD | -3491.241% |
| Peak Bio, Inc. | 2.59 Million USD | -167723.557% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -2428.563% |
| Benitec Biopharma Inc. | 52.21 Million USD | -8245.903% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -1174.618% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -12430.975% |
| Zura Bio Limited | 100.84 Million USD | -4220.97% |
| PolyPid Ltd. | 15.37 Million USD | -28246.318% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -3552.898% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -12430.975% |
| Instil Bio, Inc. | 325.63 Million USD | -1238.143% |
| argenx SE | 4.54 Billion USD | 4.074% |
| Immunome, Inc. | 148.54 Million USD | -2833.483% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -2677.623% |
| Verona Pharma plc | 308.12 Million USD | -1314.17% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -4910.863% |
| Shattuck Labs, Inc. | 159.56 Million USD | -2630.814% |
| CervoMed Inc. | 9.97 Million USD | -43594.027% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -2212.156% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -38163.049% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -2328.804% |
| Moolec Science SA | 24.05 Million USD | -18017.1% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -71128.61% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -2419.535% |
| AnaptysBio, Inc. | 452.38 Million USD | -863.197% |
| Design Therapeutics, Inc. | 289.64 Million USD | -1404.402% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -5883.379% |
| NeurAxis, Inc. | 509.49 Thousand USD | -855133.19% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -80324.437% |
| Lumos Pharma, Inc. | 40.63 Million USD | -10622.467% |
| Achilles Therapeutics plc | 161.45 Million USD | -2598.813% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -4910.863% |
| 180 Life Sciences Corp. | 5.25 Million USD | -82748.481% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -6087.04% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -50800.532% |
| Nutriband Inc. | 7.51 Million USD | -57866.033% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -1610.889% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -2086.339% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -5617.467% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -7423.648% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -727.553% |
| Palisade Bio, Inc. | 14.05 Million USD | -30909.081% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -1972.04% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -198.51% |
| Neurogene Inc. | 222.57 Million USD | -1857.738% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -573.872% |
| AEON Biopharma, Inc. | 6.84 Million USD | -63558.086% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -861.821% |
| Sesen Bio, Inc. | 189.17 Million USD | -2203.38% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -1502.768% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -31678.277% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -458.389% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -1532.02% |
| Athira Pharma, Inc. | 160.24 Million USD | -2619.209% |
| Vaccinex, Inc. | 3.63 Million USD | -119905.398% |
| HCW Biologics Inc. | 28.51 Million USD | -15181.784% |
| XOMA Corporation | 234.3 Million USD | -1759.743% |
| Nektar Therapeutics | 398.03 Million USD | -994.732% |
| Arvinas, Inc. | 1.3 Billion USD | -234.002% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -25475.576% |
| Merus N.V. | 458.49 Million USD | -850.371% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -2032.153% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -2318.035% |
| Rezolute, Inc. | 132.73 Million USD | -3182.729% |
| Clene Inc. | 52.34 Million USD | -8225.015% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -29097.478% |
| BeyondSpring Inc. | 24.8 Million USD | -17464.479% |
| Synlogic, Inc. | 75.55 Million USD | -5667.566% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -36634.075% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -46433.49% |
| Peak Bio, Inc. | 2.59 Million USD | -167723.557% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -2392.319% |
| Krystal Biotech, Inc. | 818.35 Million USD | -432.458% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -1712.274% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -500.368% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -121711.128% |
| MannKind Corporation | 475.19 Million USD | -816.964% |
| Ikena Oncology, Inc. | 192.09 Million USD | -2168.39% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -32481.098% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -3639.002% |
| Gossamer Bio, Inc. | 311.91 Million USD | -1296.977% |
| CohBar, Inc. | 16.36 Million USD | -26525.227% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -12291.992% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -59467.956% |
| Legend Biotech Corporation | 1.84 Billion USD | -135.712% |
| Mural Oncology plc | 301.74 Million USD | -1344.066% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -13859.302% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -76609.249% |
| Disc Medicine, Inc. | 367.99 Million USD | -1084.088% |
| Champions Oncology, Inc. | 26.13 Million USD | -16574.56% |
| REGENXBIO Inc. | 573.97 Million USD | -659.168% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -160803.221% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -2722.404% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -35984.362% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -1181.455% |
| Vaxart, Inc. | 91.83 Million USD | -4645.068% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -7173.979% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -2837.698% |
| Cellectis S.A. | 334.27 Million USD | -1203.556% |
| Longeveron Inc. | 12.17 Million USD | -35680.884% |
| Repare Therapeutics Inc. | 253.9 Million USD | -1616.179% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -33.475% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -2069.51% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -108.628% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -268047.446% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -1469.04% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -2571.643% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -3040.601% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -16973.098% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 80.83% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -277.618% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -35579.485% |
| Veru Inc. | 50.59 Million USD | -8512.148% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -9465.552% |
| Cingulate Inc. | 3.49 Million USD | -124702.402% |
| Passage Bio, Inc. | 150.54 Million USD | -2794.414% |
| Context Therapeutics Inc. | 16.06 Million USD | -27027.36% |
| Exicure, Inc. | 11.58 Million USD | -37528.636% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1058.734% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -2595.708% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -24839.309% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -1209.53% |
| Nuvalent, Inc. | 732.38 Million USD | -494.961% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -29058.01% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -4765.663% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -30605.348% |
| OmniAb, Inc. | 401.98 Million USD | -983.97% |
| Anew Medical, Inc. | 19.45 Million USD | -22296.21% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -16203.62% |
| Lipocine Inc. | 23 Million USD | -18844.317% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -3016.722% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -1326.013% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5091.007% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -3485.154% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -54813.623% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -393.881% |
| Ocugen, Inc. | 64.54 Million USD | -6650.734% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -3398.764% |
| Q32 Bio Inc. | 306.11 Million USD | -1323.432% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -103450.285% |
| Alumis Inc. Common Stock | 89.61 Million USD | -4762.514% |
| Equillium, Inc. | 50.53 Million USD | -8523.384% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -5694.795% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -10457.364% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -256088.865% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -16568.819% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -6661.838% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -116810.756% |
| Dominari Holdings Inc. | 57.55 Million USD | -7470.444% |
| Edesa Biotech, Inc. | 8.89 Million USD | -48912.169% |
| vTv Therapeutics Inc. | 11.01 Million USD | -39447.976% |
| Bio-Techne Corporation | 2.81 Billion USD | -54.892% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -364.978% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -436.99% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -1469.3% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -10348.89% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -552.707% |
| Nkarta, Inc. | 378.88 Million USD | -1050.058% |
| BioCardia, Inc. | 2.98 Million USD | -145778.674% |
| Iterum Therapeutics plc | 26.25 Million USD | -16493.914% |